Alembic Pharmaceuticals informs about USFDA audit

30 Jun 2016 Evaluate

Alembic Pharmaceuticals has informed that the Company’s API Facilities i.e. API I and API II both located at Panelav have been successfully inspected by the USFDA between June 20, 2016 and June 29, 2016. The Company did not receive any Form 483 observations.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

761.10 -6.05 (-0.79%)
20-Feb-2026 13:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.70
Dr. Reddys Lab 1284.95
Cipla 1335.00
Zydus Lifesciences 899.85
Lupin 2212.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×